Organized by:

Hanson Wade

Hanson Wade

52 Grosvenor Gardens, London SW1W 0AU

+44 (0)203 141 8700

Event Information

Returning for the fourth year, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.


If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.

Venue & Direction

Revere Hotel Boston Common

Boston, United States

United States

26 - 28 June, 2019

Event Speakers




Exhibitors Profile

Visitors Profile

The therapeutic potential of the human microbiome shows great promise, but in order for this potential to be realized, lessons and key insights from organizations who are directly involved in developing microbiome-based therapeutics & biomarkers must be shared and disseminated.

Event Partners